Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ROL vs GSK✓SelectedUSD · GSKROL vs GSK performance historyLatest closeAs of-2.56%11/17
Stock and ETF performance explorer

ROL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+13.4%
GSK return
+43.9%
Excess return
-30.5%
Maximum drawdown
-54.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.6%-2.3%-0.2%-2.0%
7D-0.8%-3.0%+2.2%-0.1%
30D+14.5%+0.4%+14.2%+14.4%
3M+6.4%-1.2%+7.5%+6.5%
6M-27.9%+0.9%-28.9%-28.2%
YTD-35.5%+4.0%-39.4%-36.1%
1Y-33.2%+7.3%-40.5%-34.3%
3Y+0.8%+57.1%-56.3%-9.8%
5Y+13.4%+43.0%-29.5%-3.1%
All+13.4%+43.9%-30.5%-3.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling